Literature DB >> 2790387

Presence of T-kininogen and kinins in sponge-induced exudates in rats.

J Damas1, A Adam, V Bourdon, G Remacle-Volon.   

Abstract

1. The content of kinins and T-kininogen (the third kininogen) in exudates induced by the subcutaneous implantation of saline-soaked sponges have been measured by radioimmunoassay in normal Wistar rats and in Brown Norway rats from a strain which is deficient in high and low molecular weight kininogens. 2. In both strains, sponge implantation induced a rise of T-kininogen in plasma with subsequent accumulation in the sponge exudate. This accumulation correlated with the extravasation of plasma proteins during the first 6 h. Bioassays showed that the T-kinin moiety was retained in T-kininogen. 3. In Wistar rats, a large release of immunoreactive kinins up to a mean value of 6.4 ng ml-1 was observed during the first 6 h and on the second day after the implantation. In Brown Norway rats, the kinin level in the exudates did not exceed 0.53 ng ml-1. 4. Of the kinins present during the first 6 h in the exudates withdrawn from Wistar rats, 60% were identified by high performance liquid chromatography as bradykinin. 5. The volume of the exudate induced by the implantation of dry sponges was smaller in Brown Norway rats than in Wistar rats. 6. We conclude that the role of T-kininogen in this kind of exudate was mainly the inhibition of thiol proteinases and not the release of T-kinin. In Wistar rats, bradykinin acts as a pro-inflammatory factor during the first hours and may play a role during the healing process.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2790387      PMCID: PMC1854599          DOI: 10.1111/j.1476-5381.1989.tb12598.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  23 in total

1.  Isolation and structure of T-kinin.

Authors:  H Okamoto; L M Greenbaum
Journal:  Biochem Biophys Res Commun       Date:  1983-04-29       Impact factor: 3.575

2.  T-kinin and T-kininogen--children of new technology.

Authors:  L M Greenbaum
Journal:  Biochem Pharmacol       Date:  1984-10-01       Impact factor: 5.858

3.  Congenital deficiency in plasma kallikrein and kininogens in the brown Norway rat.

Authors:  J Damas; A Adam
Journal:  Experientia       Date:  1980-05-15

4.  Stimulation of prostaglandin synthesis by bradykinin and thrombin and their mechanisms of action on MC5-5 fibroblasts.

Authors:  S L Hong; L Levine
Journal:  J Biol Chem       Date:  1976-09-25       Impact factor: 5.157

5.  Demonstration of the third kininogen in high and low molecular weight kininogens-deficient Brown Norway Katholiek rat.

Authors:  I Hayashi; T Ino; H Kato; S Iwanaga; T Nakano; S Oh-ishi
Journal:  Thromb Res       Date:  1984-12-15       Impact factor: 3.944

6.  Inflammation in the rat paw due to urate crystals. Involvement of the kinin system.

Authors:  J Damas; G Remacle-Volon; A Adam
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-01       Impact factor: 3.000

7.  Serum, bradykinin and vasopressin stimulate release of inositol phosphates from human fibroblasts.

Authors:  L M Vicentini; M L Villereal
Journal:  Biochem Biophys Res Commun       Date:  1984-09-17       Impact factor: 3.575

8.  Kininogen substrates for trypsin and cathepsin D in human, rabbit and rat plasmas.

Authors:  H Okamoto; L M Greenbaum
Journal:  Life Sci       Date:  1983-04-25       Impact factor: 5.037

9.  Hydrocortisone inhibition of the bradykinin activation of human synovial fibroblasts.

Authors:  D S Newcombe; J V Fahey; Y Ishikawa
Journal:  Prostaglandins       Date:  1977-02

10.  Measurement of urinary kallikrein activity. Species differences in kinin production.

Authors:  F Alhenc-Gelas; J Marchetti; J Allegrini; P Corvol; J Menard
Journal:  Biochim Biophys Acta       Date:  1981-11-05
View more
  1 in total

1.  Kinins and peritoneal exudates induced by carrageenin and zymosan in rats.

Authors:  J Damas; V Bourdon; G Remacle-Volon; A Adam
Journal:  Br J Pharmacol       Date:  1990-10       Impact factor: 8.739

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.